GPR30 agonists attenuate haloperidol-induced neurotoxicity in SH-SY5Y cells and adult zebrafish.
Objective: Objective:1. To investigate the neuroprotective effect of FDA-approved compounds (Raloxifene and Fulvestrant) against haloperidol-induced neurotoxicity in SHSY-5Y cells and adult zebrafish2. To explore the molecular…Oro-facial Dyskinesia and akathisia following Treatment by Olanzapine
Objective: To report the case of a pharmaco-induced oro-facial dyskinesia and akathisia. Background: Dyskinesia is a hyperkinetic, disorganized, involuntary movement disorder that can either be…Parkinson’s Disease Burden in Underserved Populations Across the US in 2022
Objective: To examine disparities in Parkinson’s disease (PD) burden by race or ethnicity, age, sex and region in the US. Background: PD is the second…Trend-Analysis of Movement Disorders, Malignant Neoplasms and Mortality from 1999-2020
Objective: We aimed to analyse the mortality and prevalence of Movement Disorders and Malignant Neoplasms from 1999-2020 in the United States to compare disparities among…Validation of the Kazakh Version of the Movement Disorder Society-Unified Dyskinesia Rating Scale.
Objective: This study aimed to validate the Kazakh version of the Movement Disorder Society-Unified Dyskinesia Rating Scale Background: The Unified Dyskinesia Rating Scale (UDysRS) has…Intelligent Assessment of Abnormal Movements in Neurological Disorders: An Update
Objective: Many neurological disorders often lead to various abnormal movements. Traditional assessment methods fail to accurately and objectively evaluate the affected muscles and the functional…Intensive Neurophysiological Rehabilitation System As a New Approach for Treatment of ASD Children
Objective: Rehabilitation of ASD children is the issue of the day as it's attributed to constantly increasing quantity of autistic children. Background: Existing rehabilitation approaches…Cross-cultural adaptation to Argentine Spanish and validation of the High Level Mobility Assessment Tool in individuals with Parkinson’s disease
Objective: To translate and adapt the High-Level Mobility Assessment Tool (HiMAT) into Argentine Spanish and evaluate its psychometric properties in individuals with Parkinson's disease (PD).…Evaluation of Effectiveness of Medical Nutrition Therapy Services for Individuals with Parkinson’s Disease: A Quality Improvement Initiative
Objective: To assess the type of dietetic consultation services used in a Parkinson Disease Center of Excellence (PDCE) for individuals with Parkinson’s disease (PD). 2.To…State of happiness as outcome measure in sleep disorders in Parkinson’s disease
Objective: The objective of this study was to evaluate state of hapiness as outcome measure in sleep disorders in PD. Background: Outcome measures are very…
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 181
- Next Page »
